Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Michael A, Marentette"'
2
Limitations of statin monotherapy for the treatment of dyslipidemia: a projection based on the Canadian lipid study – observational
Autor: Martin Sénécal, Michael A Marentette, Ruth McPherson, Claude Gagné, George Fodor, Marc-André Lavoie, Jacques Genest, Rolf J. Sebaldt
Publikováno v: Current Medical Research and Opinion. 25:47-55
Several randomized controlled trials indicate that a low density lipoprotein cholesterol (LDL-C) target2.0 mmol/L is appropriate for individuals at high risk of coronary artery disease (CAD). Recently released Canadian lipid management guidelines (20
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::603b27db6299478aed516a3e473e3282
https://doi.org/10.1185/03007990802575734
Zobrazit plný text záznamu
3
Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada
Autor: Daniel M. Huse, Michele Kohli, Chantal Bourgault, Michael A Marentette, John R. Cook, Annette Lam, Donald Yin, Cheryl L. Attard, Evo Alemao
Publikováno v: PharmacoEconomics. 24(8):815-830
Introduction: This analysis compared the cost effectiveness of adding ezetimibe to atorvastatin therapy versus atorvastatin titration or adding cholestyramine (a resin) for patients at high risk of a coronary artery disease (CAD) event who did not re
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe0feece24a93d8df0f93d5ae4caed83
http://pharmacoeconomics.adisonline.com/pt/re/phe/fulltext.00019053-200624080-00007.htm
Zobrazit plný text záznamu
4
Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study
Autor: Marc Brisson, Martin Sénécal, Michael A Marentette, Chantal Bourgault, Jean-Pierre Grégoire
Publikováno v: Journal of human hypertension. 19(8)
The objective was to assess persistence with antihypertensive therapy (AHT) and discontinuation patterns in patients newly dispensed different antihypertensive drug classes in a natural Canadian population-based setting. Hypertensive patients initiat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::241a76c83723a6fef79491d0270d8a5c
https://pubmed.ncbi.nlm.nih.gov/15920457
Zobrazit plný text záznamu
5
Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study
Autor: Rolf J, Sebaldt, Annie, Petrie, Charles H, Goldsmith, Michael A, Marentette
Publikováno v: The American journal of managed care. 10(11 Pt 1)
To assess the appropriateness of nonsteroidal anti-inflammatory drug (NSAID) use relative to recent osteoarthritis treatment guidelines from the Second Canadian Consensus Conference.Observational study of self-reported practice in a cohort of physici
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f5d7f0a7d17e7d05d01f7c5182b15785
https://pubmed.ncbi.nlm.nih.gov/15623264
Zobrazit plný text záznamu
6
Losartan reduces the costs associated with nephropathy and end-stage renal disease from type 2 diabetes: Economic evaluation of the RENAAL study from a Canadian perspective
Autor: Ellen D, Burgess, George W, Carides, William C, Gerth, Michael A, Marentette, Isabelle, Chabot
Publikováno v: The Canadian journal of cardiology. 20(6)
The Reduction of Endpoints in NIDDM [non-insulin-dependent diabetes mellitus] with the Angiotensin II Antagonist Losartan (RENAAL) study demonstrated the renoprotective effects of losartan in patients with nephropathy from type 2 diabetes.To perform
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::37a43c9f943b994c32e96dee70e96f74
https://pubmed.ncbi.nlm.nih.gov/15152291
Zobrazit plný text záznamu
7
Use of NSAIDs, COX-2 inhibitors, and acetaminophen and associated coprescriptions of gastroprotective agents in an elderly population
Autor: Sheldon X. Kong, Michael A Marentette, Elham Rahme, Jacques LeLorier
Publikováno v: Arthritis and rheumatism. 47(6)
Objectives To identify determinants of cyclooxygenase 2 (COX-2) inhibitor versus nonsteroidal antiinflammatory drug (NSAIDs) or acetaminophen prescription in seniors; and to compare gastroprotective agent coprescriptions. Methods Administrative medic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22f518770945d9e5c3ca3cf3aeda335e
https://pubmed.ncbi.nlm.nih.gov/12522832
Zobrazit plný text záznamu
8
Antihypertensive persistence and drug class
Autor: Michael A, Marentette, William C, Gerth, David K, Billings, Kelly B, Zarnke
Publikováno v: The Canadian journal of cardiology. 18(6)
Noncompliance with antihypertensive therapy is a major problem that hinders successful hypertension management.To study antihypertensive drug persistence for hypertensive patients in routine clinical settings.Hypertensive patients were retrospectivel
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::bbff6edac67469cb34470c4011edf8d8
https://pubmed.ncbi.nlm.nih.gov/12107422
Zobrazit plný text záznamu
9
SAT0230 Economic analysis of rofecoxib versus nsaids: comparison across different provinces in canada
Autor: C Sauvageau, C Attard, James M. Pellissier, Sheldon X. Kong, Michael A Marentette
Publikováno v: Speaker abstracts 2001.
Background Objectives Rofecoxib (VIOXX) patients were shown in Phase III clinical trials to have significantly fewer clinically significant gastrointestinal (GI) adverse events than those who received non-selective NSAIDs for the treatment of osteoar
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::32d37e26f14715990be98c501660af4a
https://doi.org/10.1136/annrheumdis-2001.866
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje